UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): April ~~February~~14, 032020 (March 30, 2020)

SLEEPAID HOLDING CO.

(Exact Name of Registrant as Specified in its Charter)

Nevada	000-55446	47-3785730
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS EmployerIdentification No.)
(State or Other Jurisdictionof Incorporation)	(CommissionFile Number)	(IRS Employer Identification No.)

RmRoom 10707, ~~1/F~~SoHo ~~Wellborne~~T2, ~~Commercial~~Tianshan ~~Centre8~~Plaza ~~Java~~Changing ~~RoadNorth~~District, ~~Point~~Shanghai, ~~Hong~~China ~~Kong~~200051 (Address of Principal Executive Office) (Zip Code)

Registrant’s telephone number, including area code: +86 ~~(852) 2806-2312~~13141099919

~~____________________________________________~~Rm 10 1/F Wellborne Commercial Centre

8 Java Road

North Point, Hong Kong

(former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

¨o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

~~ITEM~~ Securities ~~5.02.~~registered ~~DEPARTURE~~pursuant OFto ~~DIRECTORS~~Section OR12(b) ~~PRINCIPAL~~of ~~OFFICERS;~~the ~~ELECTION~~Act: ~~OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS~~None.

OnIndicate ~~December~~by ~~31th,~~check ~~2019,~~mark ~~Ms.~~whether ~~Qiuli Chen,~~ the ~~Chief~~registrant ~~Executive~~is ~~Director,~~an ~~and~~emerging ~~Chief~~growth ~~Financial~~company ~~Director~~as ofdefined ~~Sleepaid~~in ~~Holding~~Rule ~~Company~~405 ~~(the~~of ~~“Company”) has submitted her resignation for her personal accord to~~ the ~~board.~~Securities OnAct ~~3rd~~ of ~~February,~~1933 ~~the board accepted Ms~~(§230.405 ~~Chen’s~~of ~~resignation,~~this ~~simultaneously,~~chapter) ~~the~~or ~~board~~Rule ~~appointed~~12b-2 ~~Mr.~~of ~~Lowell Holden as~~ the ~~Chief~~Securities ~~Executive~~Exchange ~~Director,~~Act ~~Chief~~of ~~Financial~~1934 ~~Director~~(§240.12b-2 of ~~the~~this ~~Company~~chapter).

OnEmerging ~~May~~growth ~~9th,~~company 2019, Lowell Holden was appointed as a director of Sleepaid. Mr. Holden has owned and operated his own consulting firm, LS Enterprises, Inc., which provides business consulting, accounting and other services to businesses, since 1983. Mr. Holden has a broad range of business experience including managing, securing financing, structuring of transactions, and is experienced and knowledgeable in managing relationships with customers, financing institutions and stockholders. Presently Mr. Holden serves as the director and Chief Financial officer of Nascent Biotech Inc. (“NBIO”), Chief Financial Officer of Skkynet Cloud Systems, Inc. (“SKKY”), Chief Financial Officer and director of EMR Technology, and Chief Executive Officer and director of PTS, Inc. (“PTSH”). Mr. Holden also has a background in assisting companies in fulfilling their financial auditing and SEC reporting requirements. Mr. Lowell Holden has a Bachelor of Science degree from Iowa State University.x

2If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

ITEM 5.02. DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS

~~SIGNATURES~~On March 30, 2020, Lowell Holden, tendered his resignation as Chief Executive Director, Chief Financial Director and director of Sleepaid Holding Co. (the “Company”), effective immediately. On the same day, the board of directors accepted his resignation. Mr. Holden’s resignation is for personal reason and is not the result of any disagreement with the Company regarding the operations, policies or practices of the Company.

~~Pursuant~~On toMarch 30, 2020, the ~~requirements~~board of ~~the~~directors ~~Securities~~of ~~and~~the ~~Exchange~~Company ~~Act~~appointed ofMr. ~~1934,~~Huihe ~~the~~Zheng ~~Registrant~~as ~~has~~President, ~~duly~~Treasurer ~~caused~~and ~~this~~Secretary ~~Report~~ to befill ~~signed~~in onthe ~~its~~vacancies ~~behalf~~created by ~~the~~Mr. ~~undersigned~~Holden’s ~~hereunto~~resignation, ~~duly~~effective ~~authorized~~immediately.

	SLEEPAID HOLDING CO.
Date: February 3rd, 2020	By:	/s/ Lowell Holden
		Lowell Holden, CEO

Huihe Zheng, 39, has served as our director since March 2019 and is a principal stockholder of the Company. Mr. Zheng is also a principal stockholder, director and executive officer of 24/7 Kid Doc, Inc., a Florida corporation engaged in telemedicine business (OTCQB: TVMD) since March 2020. Mr. Zheng has more than twenty years of experience in investment and wealth management. Mr. Zheng has served as Chairman of Shanghai Dingchan Industrial Co., Ltd., which he founded in November 2013, a company primarily engaged in wholesale and distribution of computer equipment and components. Mr. Zheng has served as Chief Executive Officer and Chairman of Shanghai Hewu Investment Management Co., Ltd., an investment company, since he founded the company in January 2016. From 1999 to 2016, Mr. Zheng primarily focused on securities trading in stock markets in China and abroad. Mr. Zheng graduated from University of Southampton in 2019 with a bachelor’s degree in accounting and finance.

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

	SLEEPAID HOLDING CO.

Date: April 14, 2020	By:	/s/ Huihe Zheng
		Huihe Zheng
		President

Filing Compare · Sleepaid Holding Co.